Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Robotically implanted brain chip to help control external devices

Official title: UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Run by Neuralink Corp · NCT06992596 · Data updated 2026-11-12

This tests a wireless, rechargeable brain implant (Neuralink N1) and a robot surgical system (R1) to help people with severe arm and hand paralysis control external devices.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorNeuralink Corp
Industry-sponsored
Locations1 site (Abu Dhabi)
StatusRecruiting
StartedMay 9, 2025
Main results expectedNovember 2026
Study endsNovember 2027
Registry record updatedJune 5, 2025
Trial IDNCT06992596 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with chronic tetraparesis or quadriplegia (for example from cervical spinal cord injury or progressive conditions like ALS), who have a stable caregiver, can communicate, and meet surgical safety criteria.

Probably not a fit

People with uncontrolled seizures, morbid obesity (BMI > 40), high perioperative risk, or life expectancy under 12 months are unlikely to receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a feasibility study of the Neuralink N1 implant and the R1 robotic insertion system, designed to measure initial clinical safety and basic functionality in humans. The N1 is a skull‑mounted, wireless, rechargeable device connected to fine electrode threads that the R1 Robot places into the brain. Participants will be adults with long-standing bilateral upper limb motor impairment from conditions such as cervical spinal cord injury or ALS, and will undergo implantation and follow-up assessments at the study site. The primary focus is early safety and whether the system can reliably record signals that allow control of external devices.

Why it matters

Potential benefit: If successful, the implant could allow people with severe paralysis to control computers, phones, or assistive devices more directly and independently.

How similar studies have gone: Prior intracortical brain–computer interface work (for example BrainGate and other implant systems) has shown proof-of-concept control of cursors and robotic devices, but the Neuralink N1 and R1 robot approach is novel and early in human testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (a) A diagnosis of a spinal cord injury (\>12 months), stroke (\>12 months), or other neurological condition causing the participant to experience bilateral upper limb motor impairment, with no expectation of recovery.

OR (b) A diagnosis of Amyotrophic Lateral Sclerosis (ALS) or other progressive neurological condition where the natural history of the disease is well understood and where there is tetraparesis and the expectation, in the view of the participant's treating neurologist, that the disease will progress such that the participant will meet criteria 1a within 1 year of recruitment.

* Life expectancy ≥ 12 months.
* Ability to communicate verbally or with the use of a computer or communication aid, and working proficiency in English.
* Presence of a stable caregiver

Exclusion Criteria:

* Moderate to high risk for serious perioperative adverse events
* Morbid obesity (Body Mass Index \> 40)
* History of poorly controlled seizures or epilepsy
* History of poorly controlled diabetes
* Requires magnetic resonance imaging (MRI) for any ongoing medical conditions
* Acquired or hereditary immunosuppression
* Smoking tobacco or use of other tobacco products \> once per month within the last year.
* Psychiatric or psychological disorder
* Pre-existing damage to the cortical region of interest (as determined by MRI)
* Any condition which, in the opinion of the Investigator, would compromise your ability to safely participate in the study or undergo the implantation procedure

Where it's running

  • Cleveland Clinic Abu Dhabi (CCAD)
    Abu Dhabi, United Arab Emirates
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.